This federal contract award is for the procurement of an Agilent Seahorse XF Flex system, a specialized laboratory instrument for measuring metabolism in patient samples and experimental models. The contract, valued at $198,759.37, was awarded to Agilent Technologies Inc. by the National Heart Lung and Blood Institute, which operates under the Department of Health and Human Services National Institutes of Health. The award does not utilize any set-aside designations, indicating it was competitively awarded. The original federal contract opportunity was a Special Notice posted on September 12, 2025, with a due date of September 17, 2025, seeking to replace an existing shared metabolic analyzer. The contract has an ultimate completion date of October 25, 2025. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing advanced analytical instruments, software, services, and consumables to federal agencies. This contract award supports the National Heart Lung and Blood Institute's research operations and laboratory functions by providing specialized scientific equipment essential for metabolic analysis.
Generated 9/26/25, 10:00 AM